| # | Title | Journal | Year | Citations |
|---|
| 1 | The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future | Neuropsychopharmacology | 2017 | 364 |
| 2 | Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin | Scientific Reports | 2017 | 266 |
| 3 | The Development of the ICD-11 Classification of Personality Disorders: An Amalgam of Science, Pragmatism, and Politics | Annual Review of Clinical Psychology | 2019 | 211 |
| 4 | Psychedelics, Meditation, and Self-Consciousness | Frontiers in Psychology | 2018 | 179 |
| 5 | British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update | Journal of Psychopharmacology | 2019 | 173 |
| 6 | British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 | Journal of Psychopharmacology | 2017 | 166 |
| 7 | Psychedelics and connectedness | Psychopharmacology | 2018 | 154 |
| 8 | Methodological Recommendations for Trials of Psychological Interventions | Psychotherapy and Psychosomatics | 2018 | 146 |
| 9 | Neural correlates of the DMT experience assessed with multivariate EEG | Scientific Reports | 2019 | 144 |
| 10 | The relationship between negative symptoms and depression in schizophrenia: a systematic review | Acta Psychiatrica Scandinavica | 2018 | 133 |
| 11 | The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial | Lancet Psychiatry,the | 2018 | 133 |
| 12 | Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression | Neuropharmacology | 2018 | 126 |
| 13 | Fathers, fathering and child psychopathology | Current Opinion in Psychology | 2017 | 123 |
| 14 | DMT Models the Near-Death Experience | Frontiers in Psychology | 2018 | 122 |
| 15 | Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder | JAMA - Journal of the American Medical Association | 2017 | 104 |
| 16 | The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial | Psychopharmacology | 2019 | 86 |
| 17 | Nonsuicidal self‐injury in community adolescents: A systematic review of prospective predictors, mediators and moderators | Journal of Adolescence | 2018 | 85 |
| 18 | OpenSIMPLe: A real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder | Journal of Affective Disorders | 2018 | 72 |
| 19 | Practitioner Review: Mental health problems of refugee children and adolescents and their management | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2019 | 67 |
| 20 | Mental and sexual health outcomes following sexual assault in adolescents: a prospective cohort study | The Lancet Child and Adolescent Health | 2018 | 60 |
| 21 | Mental imagery in psychiatry: conceptual & clinical implications | CNS Spectrums | 2019 | 60 |
| 22 | Refugees in Europe: national overviews from key countries with a special focus on child and adolescent mental health | European Child and Adolescent Psychiatry | 2018 | 59 |
| 23 | Consciousness is supported by near-critical slow cortical electrodynamics | Proceedings of the National Academy of Sciences of the United States of America | 2022 | 56 |
| 24 | Video games for the assessment and treatment of attention-deficit/hyperactivity disorder: a systematic review | European Child and Adolescent Psychiatry | 2022 | 55 |
| 25 | Recent Advances in the Understanding and Treatment of Health Anxiety | Current Psychiatry Reports | 2018 | 54 |
| 26 | Nidotherapy compared with enhanced care programme approach training for adults with aggressive challenging behaviour and intellectual disability (NIDABID): cluster‐randomised controlled trial | Journal of Intellectual Disability Research | 2017 | 53 |
| 27 | Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study | BMC Medicine | 2018 | 51 |
| 28 | The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective | Frontiers in Psychiatry | 2018 | 47 |
| 29 | Increase in the prevalence of health anxiety in medical clinics: Possible cyberchondria | International Journal of Social Psychiatry | 2019 | 46 |
| 30 | Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial | Trials | 2016 | 45 |
| 31 | Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder? | Journal of Affective Disorders | 2017 | 45 |
| 32 | Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder | Psychological Medicine | 2019 | 44 |
| 33 | A randomized controlled trial reporting functional outcomes of cognitive–behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology | European Archives of Psychiatry and Clinical Neuroscience | 2017 | 43 |
| 34 | Prevention of psychological distress and promotion of resilience amongst unaccompanied refugee minors in resettlement countries | Child: Care, Health and Development | 2019 | 41 |
| 35 | Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study | British Journal of Psychiatry | 2020 | 39 |
| 36 | Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression | Journal of Affective Disorders | 2018 | 37 |
| 37 | Neural response during emotion regulation in monozygotic twins at high familial risk of affective disorders | NeuroImage: Clinical | 2019 | 34 |
| 38 | Cognitive–behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years | Health Technology Assessment | 2017 | 34 |
| 39 | Diagnosis and classification of personality disorders | Current Opinion in Psychiatry | 2019 | 32 |
| 40 | The role of Hebbian learning in human perception: a methodological and theoretical review of the human Visual Long-Term Potentiation paradigm | Neuroscience and Biobehavioral Reviews | 2020 | 29 |
| 41 | Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II | Journal of Contextual Behavioral Science | 2020 | 28 |
| 42 | Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment | Brain, Behavior, and Immunity | 2021 | 28 |
| 43 | International multicentre randomised controlled trial of improvisational music therapy for children with autism spectrum disorder: TIME-A study | Health Technology Assessment | 2017 | 27 |
| 44 | Staff and patient experiences of decision-making about continuous observation in psychiatric hospitals | Social Psychiatry and Psychiatric Epidemiology | 2017 | 25 |
| 45 | Lamotrigine for people with borderline personality disorder: a RCT | Health Technology Assessment | 2018 | 24 |
| 46 | Dissecting the elements of borderline personality disorder | Personality and Mental Health | 2018 | 23 |
| 47 | Human Sensory LTP Predicts Memory Performance and Is Modulated by the BDNF Val66Met Polymorphism | Frontiers in Human Neuroscience | 2019 | 23 |
| 48 | Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals | Molecular Psychiatry | 2020 | 23 |
| 49 | Psychiatric hospital beds: an Orwellian crisis | Lancet, The | 2017 | 22 |
| 50 | What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication | Psychological Medicine | 2017 | 21 |
